A direct window into the behavior of tumor cells and viruses in your body

How can we know if a treatment for cancer or infection is really working?
Nagalasa analysisis an advanced clinical tool that measures the activity of a key enzyme produced by tumor cells and certain viruses, providing an early, effective, and non-invasive marker for monitoring immune status and therapeutic efficacy in real time.

This test measures the activity of theenzyme alpha-N-acetylgalactosaminidase (Nagalase)in the blood, a secreted protein:

• Bytumor cellsduring cancer progression and invasion.
• Due toviruses such as HIV and influenza, or in chronic infections such asLyme disease.

An increase in Nagalasa levels may indicate:

• Active tumor proliferationin various types of cancer: breast, colon, lung, prostate, ovary, among others.
• Active viral load or persistent chronic infections.
• Failure or poor effectiveness of current treatments.

More information at:analisis@biosalud.org

Key benefits compared to other analyses

• High clinical sensitivity: detectssubtle changes that other markers overlook.
• Rapid response to therapeutic changes, idealfor precisely adjusting treatments.
• No biopsiesorinvasive proceduresare required.
• Supports informed clinical decisions, improvingthe personalized approach to the patient.
• Reliable periodic monitoring thanksto the short half-life of the enzyme.